Treatment of the Painful Motion Segment

Patient randomization is performed using a 1:1 ratio of ProDisc-C recipients to ACDF control recipients in the treatment of symptomatic cervical disc disease at only one level between C3 and C7. To date, 30 patients have been enrolled in the FDA study, and the early 6- and 12-month data are now available (Delamarter RB, Pradham BB. Indications for cervical spine prostheses. Early experience ... ................
................